Alnylam Pharmaceuticals (ALNY) 'Appears Oversold' on BridgeBio Pharma News - Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 162.29 +2.40 (1.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $159.89 | 52 Week High | $109.10 | |||
| Open | $166.73 | 52 Week Low | $31.38 | |||
| Day High | $170.49 | P/E | N/A | |||
| Day Low | $160.29 | EPS | $-1.45 | |||
| Volume | 999,019 | |||||
